5 companies in Atlas Venture's investment portfolio.
Back to Atlas Venture profile“Venture creation firm building breakthrough biotech startups in partnership with exceptional entrepreneurs and scientists.”
Clinical-stage biopharmaceutical company developing small molecule drugs for genetically defined diseases using gene modulation approach.
A biotechnology company developing cancer immunotherapies using CRISPR-based functional genomics to identify novel drug targets.
A clinical-stage biopharmaceutical company developing precision medicines using targeted protein degradation technology for cancer and inflammatory diseases.
Clinical-stage precision medicine company using computational approaches to develop protein motion-based therapies for cancer.
Tango Therapeutics develops precision oncology medicines using synthetic lethality approaches to target cancer vulnerabilities created by tumor suppressor gene loss.
Atlas Venture has built a portfolio of 5 companies across 1 sector, including Biotech.
The portfolio reflects investments across the IPO, Series A stages, showing Atlas Venture's approach to supporting companies at multiple points in their growth journey.
Atlas Venture has invested in 5+ companies across 1 different sectors.
Atlas Venture's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
Atlas Venture invests across the IPO, Series A stages. Their portfolio includes companies at various points in their growth journey.